A detailed history of Cullinan Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Cullinan Associates Inc holds 64,904 shares of PFE stock, worth $1.72 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
64,904
Previous 262,084 75.24%
Holding current value
$1.72 Million
Previous $7.33 Million 74.39%
% of portfolio
0.1%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$27.7 - $31.39 $5.46 Million - $6.19 Million
-197,180 Reduced 75.24%
64,904 $1.88 Million
Q2 2024

Jul 10, 2024

SELL
$25.26 - $29.6 $407,140 - $477,092
-16,118 Reduced 5.79%
262,084 $7.33 Million
Q1 2024

Apr 18, 2024

BUY
$25.89 - $29.73 $2.16 Million - $2.48 Million
83,384 Added 42.8%
278,202 $7.72 Million
Q4 2023

Jan 24, 2024

SELL
$26.13 - $33.94 $2.4 Million - $3.12 Million
-91,992 Reduced 32.07%
194,818 $5.61 Million
Q3 2023

Oct 11, 2023

SELL
$32.09 - $37.51 $956,282 - $1.12 Million
-29,800 Reduced 9.41%
286,810 $9.51 Million
Q2 2023

Jul 14, 2023

SELL
$36.12 - $41.79 $325,585 - $376,695
-9,014 Reduced 2.77%
316,610 $11.6 Million
Q1 2023

Apr 05, 2023

BUY
$39.39 - $51.28 $2.92 Million - $3.8 Million
74,155 Added 29.49%
325,624 $13.3 Million
Q4 2022

Jan 11, 2023

BUY
$41.75 - $54.5 $3,173 - $4,142
76 Added 0.03%
251,469 $12.9 Million
Q3 2022

Oct 19, 2022

BUY
$43.76 - $53.42 $845,968 - $1.03 Million
19,332 Added 8.33%
251,393 $11 Million
Q2 2022

Jul 08, 2022

BUY
$46.53 - $55.17 $2.16 Million - $2.56 Million
46,392 Added 24.99%
232,061 $12.2 Million
Q1 2022

Apr 21, 2022

BUY
$45.75 - $56.69 $4.2 Million - $5.21 Million
91,816 Added 97.83%
185,669 $9.61 Million
Q4 2021

Jan 07, 2022

BUY
$41.32 - $61.25 $495,137 - $733,958
11,983 Added 14.64%
93,853 $5.54 Million
Q3 2021

Oct 08, 2021

SELL
$39.25 - $50.42 $6.63 Million - $8.52 Million
-168,900 Reduced 67.35%
81,870 $3.52 Million
Q2 2021

Jul 07, 2021

SELL
$35.91 - $40.68 $1.01 Million - $1.15 Million
-28,177 Reduced 10.1%
250,770 $9.82 Million
Q1 2021

Apr 20, 2021

SELL
$33.49 - $37.77 $904 - $1,019
-27 Reduced 0.01%
278,947 $10.1 Million
Q4 2020

Jan 14, 2021

BUY
$33.47 - $42.56 $601,556 - $764,930
17,973 Added 6.89%
278,974 $10.3 Million
Q3 2020

Oct 09, 2020

BUY
$31.75 - $37.25 $127,000 - $149,000
4,000 Added 1.56%
261,001 $9.58 Million
Q2 2020

Jul 07, 2020

BUY
$30.12 - $36.54 $54,095 - $65,625
1,796 Added 0.7%
257,001 $8.4 Million
Q1 2020

Apr 01, 2020

BUY
$27.03 - $38.62 $127,473 - $182,131
4,716 Added 1.88%
255,205 $8.33 Million
Q4 2019

Jan 15, 2020

BUY
$32.92 - $37.36 $95,040 - $107,858
2,887 Added 1.17%
250,489 $9.81 Million
Q3 2019

Oct 01, 2019

SELL
$32.49 - $42.13 $30,833 - $39,981
-949 Reduced 0.38%
247,602 $8.9 Million
Q2 2019

Jul 16, 2019

BUY
$36.98 - $41.52 $270,878 - $304,134
7,325 Added 3.04%
248,551 $10.8 Million
Q1 2019

Apr 30, 2019

SELL
$37.5 - $41.2 $165,937 - $182,310
-4,425 Reduced 1.8%
241,226 $10.2 Million
Q4 2018

Jan 11, 2019

SELL
$38.47 - $43.86 $215,432 - $245,616
-5,600 Reduced 2.23%
245,651 $10.7 Million
Q3 2018

Oct 19, 2018

SELL
$34.47 - $41.81 $821,902 - $996,917
-23,844 Reduced 8.67%
251,251 $11.1 Million
Q2 2018

Jul 09, 2018

SELL
$32.98 - $35.16 $600,236 - $639,911
-18,200 Reduced 6.21%
275,095 $9.98 Million
Q1 2018

Apr 27, 2018

SELL
$31.91 - $37.02 $504,848 - $585,693
-15,821 Reduced 5.12%
293,295 $10.4 Million
Q4 2017

Jan 17, 2018

BUY
$33.26 - $35.29 $53,216 - $56,464
1,600 Added 0.52%
309,116 $11.2 Million
Q3 2017

Oct 16, 2017

BUY
$31.0 - $34.15 $9.53 Million - $10.5 Million
307,516
307,516 $11 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cullinan Associates Inc Portfolio

Follow Cullinan Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.